We are live on
!
Find out more
GCM
Garland Capital Management Portfolio holdings
AUM
$7.27M
1-Year Est. Return
14.85%
This Fund
S&P 500
This Quarter
Est. Return
+6.02%
1 Year Est. Return
+14.85%
3 Year Est. Return
+55.71%
5 Year Est. Return
+87%
10 Year Est. Return
+180.2%
AUM
$152M
AUM Growth
-$3.97M
(-2.5%)
Cap. Flow
-$12.2M
Cap. Flow
% of AUM
-8.02%
Top 10 Holdings %
Top 10 Hldgs %
38.07%
Holding
34
New
–
Increased
16
Reduced
16
Closed
2
Avg Time Held
11.4
quarters
Top 10 Avg Time Held
6.8
quarters
Top 20 Avg Time Held
8.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$188K |
| 2 |
Merck
MRK
|
+$183K |
| 3 |
IBM
IBM
|
+$140K |
| 4 |
Simon Property Group
SPG
|
+$123K |
| 5 |
AT&T
T
|
+$75.4K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$4.05M |
| 2 |
Public Storage
PSA
|
+$3.54M |
| 3 |
Microsoft
MSFT
|
+$1.3M |
| 4 |
Johnson & Johnson
JNJ
|
+$817K |
| 5 |
Prologis
PLD
|
+$786K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 21.2% |
| 2 | Healthcare | 19.74% |
| 3 | Financials | 17.63% |
| 4 | Technology | 14.08% |
| 5 | Industrials | 10.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
JPMorgan Chase
JPM
$889B
| $6.49M | 4.26% |
60,715
-1,540
| -2% | -$156K |
2013 Q2
18 quarters
|
|
|
2
Microsoft
MSFT
$4.02T
| $6.44M | 4.23% |
75,326
-15,887
| -17% | -$1.3M |
2013 Q2
18 quarters
|
|
3
3M
MMM
$83.2B
| $6M | 3.94% |
30,488
-3,182
| -9% | -$612K |
2013 Q2
18 quarters
|
|
|
4
Johnson & Johnson
JNJ
$634B
| $5.94M | 3.9% |
42,512
-5,868
| -12% | -$817K |
2013 Q2
18 quarters
|
|
5
AbbVie
ABBV
$494B
| $5.72M | 3.76% |
59,201
-8,055
| -12% | -$759K |
2016 Q1
7 quarters
|
|
6
Pfizer
PFE
$162B
| $5.72M | 3.76% |
166,515
-754
| -0.5% | -$25.7K |
2013 Q2
18 quarters
|
|
7
Prudential Financial
PRU
$39.1B
| $5.58M | 3.67% |
48,575
-925
| -2% | -$104K |
2013 Q2
18 quarters
|
|
8
Qualcomm
QCOM
$185B
| $5.41M | 3.55% |
84,445
+245
| +0.3% | +$14.9K |
2017 Q2
2 quarters
|
|
9
Chevron
CVX
$422B
| $5.38M | 3.53% |
42,998
-740
| -2% | -$87.7K |
2013 Q2
18 quarters
|
|
10
Cisco
CSCO
$456B
| $5.29M | 3.47% |
138,011
-1,715
| -1% | -$61.3K |
2013 Q4
16 quarters
|
|
11
RTX Corp
RTX
$252B
| $5.17M | 3.4% |
64,434
+40
| +0.1% | +$3.04K |
2013 Q2
18 quarters
|
|
12
Travelers Companies
TRV
$77.6B
| $5.03M | 3.3% |
37,100
-1,375
| -4% | -$181K |
2014 Q2
14 quarters
|
|
13
Union Pacific
UNP
$167B
| $4.96M | 3.26% |
37,018
+325
| +0.9% | +$39.2K |
2015 Q3
9 quarters
|
|
14
Bank of New York Mellon
BNY
$97.2B
| $4.9M | 3.22% |
91,005
-145
| -0.2% | -$7.72K |
2017 Q2
2 quarters
|
|
15
Blackrock
BLK
$168B
| $4.83M | 3.17% |
9,410
-75
| -0.8% | -$36.5K |
2017 Q2
2 quarters
|
|
16
Procter & Gamble
PG
$355B
| $4.66M | 3.06% |
50,712
+435
| +0.9% | +$39.1K |
2013 Q2
18 quarters
|
|
17
PepsiCo
PEP
$173B
| $4.61M | 3.02% |
38,415
-125
| -0.3% | -$14.3K |
2013 Q2
18 quarters
|
|
|
LPT
18
DELISTED
Liberty Property Trust
LPT
| $4.55M | 2.99% |
105,790
+550
| +0.5% | +$23.9K |
2013 Q2
18 quarters
|
|
19
Alexandria Real Estate Equities
ARE
$7.53B
| $4.48M | 2.94% |
34,340
-5,640
| -14% | -$710K |
2017 Q2
2 quarters
|
|
|
20
Prologis
PLD
$125B
| $4.48M | 2.94% |
69,492
-12,038
| -15% | -$786K |
2017 Q2
2 quarters
|
|
21
Novartis
NVS
$273B
| $4.38M | 2.88% |
58,292
+597
| +1% | +$45K |
2013 Q2
18 quarters
|
|
|
22
IBM
IBM
$213B
| $4.32M | 2.83% |
29,420
+963
| +3% | +$140K |
2013 Q2
18 quarters
|
|
|
23
Merck
MRK
$358B
| $4.18M | 2.75% |
77,919
+3,307
| +4% | +$183K |
2017 Q2
2 quarters
|
|
24
Highwoods Properties
HIW
$3.25B
| $4.11M | 2.7% |
80,725
+150
| +0.2% | +$7.73K |
2015 Q3
9 quarters
|
|
|
25
AT&T
T
$154B
| $4.11M | 2.7% |
139,981
+2,760
| +2% | +$75.4K |
2017 Q2
2 quarters
|
|
Similar funds
HL
IIGPLP
LSC
CG
LFA
SGIHM
TAC
YU
Garland Capital Management's Q4 2017 Portfolio in Review
As of Q4 2017, Garland Capital Management held 34 positions worth $152M, down 2.5% from $156M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Garland Capital Management withdrew a net $12.2M in Q4 2017, closing 2 positions and reducing 16 holdings. Its most notable exit was GE Aerospace, an estimated $4.05M position sold in full.
By sector, the portfolio is most concentrated in Real Estate at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Garland Capital Management added an estimated $188K to CVS Health.
- Garland Capital Management added most to CVS Health in Q4 2017, an estimated $188K increase.
- Garland Capital Management's biggest Q4 2017 reduction was Microsoft, cutting an estimated $1.3M.
- Garland Capital Management fully exited GE Aerospace in Q4 2017, selling an estimated $4.05M.
- Garland Capital Management's ten largest holdings make up 38% of its $152M portfolio in Q4 2017.
- Garland Capital Management opened 0 new positions and closed 2 in Q4 2017.
- Garland Capital Management's portfolio value fell 2.5% quarter-over-quarter to $152M.
Based on Garland Capital Management's 13F filing for Q4 2017, filed 25 Jan 2018.